BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32548851)

  • 1. HIP1R acts as a tumor suppressor in gastric cancer by promoting cancer cell apoptosis and inhibiting migration and invasion through modulating Akt.
    Zhu J; Wang X; Guan H; Xiao Q; Wu Z; Shi J; Zhang F; Gao P; Song Y; Wang Z
    J Clin Lab Anal; 2020 Sep; 34(9):e23425. PubMed ID: 32548851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
    Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
    Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Liu Q
    J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation and miR-92a-3p-mediated repression of HIP1R promotes pancreatic cancer progression by activating the PI3K/AKT pathway.
    Zhu S; Xu H; Chen R; Shen Q; Yang D; Peng H; Tong J; Fu Q
    J Cell Mol Med; 2023 Mar; 27(6):788-802. PubMed ID: 36811277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
    Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of TRPV1 ion channels in the suppression of gastric cancer development.
    Gao N; Yang F; Chen S; Wan H; Zhao X; Dong H
    J Exp Clin Cancer Res; 2020 Oct; 39(1):206. PubMed ID: 33008449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signaling pathways.
    Wang Y; Xiao H; Wang C; Wu H; He H; Yao C; Cui J; Li W
    J Cell Biochem; 2020 Mar; 121(3):2330-2342. PubMed ID: 31692032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.
    Ding L; Zhao Y; Dang S; Wang Y; Li X; Yu X; Li Z; Wei J; Liu M; Li G
    Mol Cancer; 2019 Mar; 18(1):45. PubMed ID: 30922402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer.
    Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R
    Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
    Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
    PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACBD3 is up-regulated in gastric cancer and promotes cell cycle G1-to-S transition in an AKT-dependent manner.
    Zheng Y; Pei Y; Tang R; Zhou X; Feng Z; Li D; Chen H; Zeng Z; Jiang L; Cai J; Mao P; Wang L
    Exp Cell Res; 2021 Sep; 406(2):112752. PubMed ID: 34332983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
    Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
    Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.
    He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H
    Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.